Combination of silver nanoparticles and Drosera binata extract as a possible alternative for antibiotic treatment of burn wound infections caused by resistant Staphylococcus aureus

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Krychowiak, Marta ^a   Grinholc, Mariusz ^a   Banasiuk, Rafal ^a   Krauze Baranowska, Miroslawa ^b   Głód, Daniel ^b   Kawiak, Anna ^a   Królicka, Aleksandra ^a  

^a UNIVERSITY OF GDA SK   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

3 CHLOROPLUMBAGIN; 3,3' DI O METHYLELLAGIC ACID; ANTIINFECTIVE AGENT; DROSERA BINATA EXTRACT; DROSERONE; ELLAGIC ACID; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PLUMBAGIN; SILVER NANOPARTICLE; UNCLASSIFIED DRUG; METAL NANOPARTICLE; NAPHTHOQUINONE; SILVER; SILVER DERIVATIVE;

ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; BURN INFECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; STAPHYLOCOCCUS INFECTION; BIOFILM; BURN; CELL CULTURE; DROSERA; DRUG EFFECTS; KERATINOCYTE; METABOLISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; PATHOGENICITY; WOUND INFECTION;

DROSERA BINATA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BIOFILMS; BURNS; CELLS, CULTURED; DROSERA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; KERATINOCYTES; METAL NANOPARTICLES; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; NAPHTHOQUINONES; PLANT EXTRACTS; SILVER; SILVER COMPOUNDS; WOUND INFECTION;

EID: 84938347380     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115727     Document Type: Article

References (36)

1. Tsymbal A, Pechenizkiy M, Puuronen S, Shifrin M, Alexandrova I (2005) Knowledge discovery in microbiology data: analysis of antibiotic resistance in nosocomial infections. In: Internatiol Workshop on Current Aspects of Knowledge Management in Medicine, KMM05, in conjunction with the 3rd Int. Conf. on Professional Knowledge Management: Experiences and Visions, Kaiserslautern, Germany, Lecture Notes in Computer Science, Springer.
2. Church D, Elsayed S, Reid O, Winston B, Lindsay R (2006) Burn Wound Infections. Clinical Microbiol Rev 19: 403-434.
3. Stewart PS, Costerton JW (2001) Antibiotic resistance of bacteria in biofilms. Lancet 358: 135-138.
4. Lowy FD (2003) Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 111: 1265-1273.
5. Machado TB, Pinto AV, Pinto MC, Leal IC, Silva MG, et al. (2003) In vitro activity of Brazilian medicinal plants, naturally occurring naphthoquinones and their analogues, against methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 21(3): 279-284.
6. Allaker RP, Memarzadeh K (2014) Nanoparticles and the control of oral infections. Int J Antimicrob Agents 43: 95-104.
7. Sondi I, Salopek-Sondi B (2004) Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for gram-negative bacteria. J Colloid Interface Sci 275: 177-182.
8. Kawiak A, Królicka A, Łojkowska E (2003) Direct regeneration of Drosera from leaf explants and shoot tips. Plant Cell Tiss Organ Cult 75: 175-178.
9. Zehl M, Braunberger C, Conrad J, Crnogorac M, Krasteva S, et al. (2011) Identification and quantification of flavonoids and ellagic acid derivatives in therapeutically important Drosera species by LC-DAD, LC-NMR, NMR and LC-MS. Anal Bioanal Chem 400: 2565-2576.
10. Królicka A, Szpitter A, Gilgenast E, Romanik G, Kamiński M, et al. (2008) Stimulation of antibacterial naphthoquinones and flavonoids accumulation in carnivorous plants grown in vitro by addition of elicitors. Enzyme Microbial Technol 42: 216-221.
11. Williamson EM (2001) Synergy and other interactions in phytomedicines. Phytomedicine 8(5): 401-409.
12. Wagner H, Ulrich-Merzenich G (2009) Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine 16: 97-110.
13. Davis SC, Ricotti C, Cazzaniga A, Welsh E, Eaglstein WH, et al. (2008) Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo. Wound Repair Regen 16: 23-29.
14. Kalishwaralal K, BarathManiKanth S, Pandian SR, Deepak V, Gurunathan S (2010) Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Surf B Biointerfaces 79(2): 340-344.
15. Daglia M (2012) Polyphenols as antimicrobial agents. Curr Opin Biotechnol 23: 174-181.
16. Kreher B, Neszmélyi A, Wagner H (1990) Naphthoquinones from Dionaea muscipula. Phytochemistry 29(2): 605-606.
17. Nair AGR, Shanmugasundaram P, Madhusudhanan KP (1990) Naphthaquinones and flavonols from leaves of Drosera peltata. J Fitoterapia 61(1): 85-86.
18. Bringmann G, Rischer H, Wohlfarth M, Schlauer J, Assi LA (2000) Droserone from cell cultures of Triphyophyllum peltatum (Dioncophyllaceae) and its biosynthetic origin. Phytochemistry 53(3): 339-343.
19. Sidhu GS, Sankaram AVB (1971) A new biplumbagin and 3-chloroplumbagin from Plumbago zeylanica. Tetrahedron Lett 12(26): 2385-2388.
20. Krishnamoorthy V, Thomson RH (1969) A new binaphthaquinone from Drosera ramentacea. Phytochemistry 8: 1591-1594.
21. Higa M, Ogihara K, Yogi S (1998) Bioactive naphthoquinone derivatives from Diospyros maritime BLUME. Chem Pharm Bull 46(8): 1189-1193.
22. Bendz G, Lindberg G (1968) Naphthoquinones and anthocyanins from two Drosera species. Acta Chem Scan 22(8): 2722-2723.
23. Engvild KC (1986) Chlorine-containing natural compounds in higher plant. Phytochemistry 25(4): 781-791.
24. Hernández-Muñoz LS, Gómez M, González FJ, González I, Frontana C (2009) Towards a molecular-level understanding of the reactivity differences for radical anions of juglone and plumbagin: an electrochemical and spectroelectrochemical approach. Org Biomol Chem 7: 1896-1903.
25. Lakshmi VV, Padma S and Polasa H (1987) Elimination of multidrug-resistant plasmid in bacteria by plumbagin, a compound derived from a plant. Curr Microbiol 16: 159-161.
26. García-Barrasa J, López-de-Luzuriaga JM, Monge M (2011) Silver nanoparticles: synthesis through chemical methods in solution and biomedical applications. Cent Eur J Chem 9: 7-19.
27. Kuo PL, Hsu YL, Cho CY (2006) Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/ mammalian target of rapamycin pathway in breast cancer cells. Mol Cancer Therap 5: 3209-3221.
28. Murray CK (2007) Infections in burns. J Trauma 62: 73.
29. Murashige T, Skoog F (1962) A revised medium for rapid growth and bioassays with tobacco tissue cultures. Physiol Plantarum 15: 473-497.
30. CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard - Ninth Edition. CLSI document M07-A9. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
31. CLSI. Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline. CLSI document M26-A. Wayne, PA: Clinical and Laboratory Standards Institute, 1999.
32. Razzakova DM, Bessonova IA, Yunusov SY (1973) Alkaloids of Haplophyllum acutifolium. Khimiya Prirodnykh Soedinenii [Chemistry of Natural Compounds] 2: 206-210.
33. Behrman EJ, Kiser RL, Garas WF, Behrman EC, Pitt BM (1995) Conversion of 4-quinolones into 3-hydroxy-4-quinolones via the corresponding sulfates. J Chem Res Synop 5: 1051-1063.
34. Harrison JJ, Stremick CA, Turner RJ, Allan ND, Olson ME, et al. (2010) Microtiter susceptibility testing of microbes growing on peg lids: a miniaturized biofilm model for high-throughput screening. Nature Protocols 5(7): 1236-1254.
35. Thornsberry C (1991) Antimicrobial susceptibility testing of anaerobic bacteria: review, comments, and opinions. Ann Otology Rhinology Laryngology Suppl 154: 7-10.
36. Barenbaum MC (1978) A method for testing for synergy with any number of agents. J Infection Dis 137(2): 122-130.